Sarepta Therapeutics
(NQ:
SRPT
)
128.92
-4.85 (-3.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sarepta Therapeutics
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
10 Health Care Stocks Whale Activity In Today's Session
March 16, 2023
Via
Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Meta Platforms To Rally 27%? Here Are 10 Other Analyst Forecasts For Thursday
March 09, 2023
Wells Fargo cut the price target for SVB Financial Group (NASDAQ: SIVB) from $350 to $300. Wells Fargo analyst Steven Shaw maintained an Overweight rating. SVB Financial shares fell 29.1% to $190.02 in...
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
March 09, 2023
Regeneron and Sarepta Therapeutics have been on fire so far this year.
Via
The Motley Fool
The Latest Analyst Ratings for Sarepta Therapeutics
March 03, 2023
Via
Benzinga
Novavax Stock Down On Concern Over Whether The Company Can Continue
February 28, 2023
Novavax warns that it may not be able to continue as a company.
Via
Talk Markets
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Via
Benzinga
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
March 03, 2023
Many leaders flashed buy signals as the indexes rebounded from support.
Via
Investor's Business Daily
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
The company's latest Duchenne muscular dystrophy gene therapy may have an accelerated approval.
Via
The Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
These three red-hot growth stocks have more room to run.
Via
The Motley Fool
Why Sarepta Therapeutics Stock Is Booming Today
March 01, 2023
Sarepta Therapeutics (NASDAQ: SRPT) shares are trading higher this Wednesday after the company reported better-than-expected fourth-quarter results.
Via
Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Why This Sarepta Therapeutics Is Turning Bullish
March 01, 2023
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) jumped in early trading on Wednesday, after the company reported an earnings beat for its fourth quarter.
Via
Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Sarepta Rockets And Breaks Out As FDA Smooths The Path For Its Gene Therapy
March 01, 2023
The FDA will not hold an advisory committee meeting for the company's gene therapy.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today?
March 01, 2023
Sarepta Therapeutics (SRPT) stock is heading higher on Wednesday following the release of its latest earnings report and an upgrade.
Via
InvestorPlace
Investors Just Hit the Jackpot on These 2 Nasdaq Biotech Stocks
March 01, 2023
Markets are trying to rise, and these companies are helping out.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 01, 2023
Via
Benzinga
Sarepta Therapeutics To Rally Over 53%? Here Are 10 Other Analyst Forecasts For Wednesday
March 01, 2023
Keybanc raised the price target for Ambarella, Inc. (NASDAQ: AMBA) from $95 to $105. Keybanc analyst John Vinh maintained an Overweight rating. Ambarella shares fell 7.1% to $87.61 in pre-market...
Via
Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 01, 2023
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
February 28, 2023
SRPT earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 28, 2023
From
Sarepta Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via
Benzinga
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
February 28, 2023
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Announces Call for Applications for the 6th Annual Route 79, The Duchenne Scholarship Program
February 28, 2023
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results
February 21, 2023
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Sarepta Therapeutics Announces Initiation of VOYAGENE, a Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4
February 17, 2023
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.